HEALTH QUEST'S NEW DIVISION OF NEUROINTERVENTIONAL SURGERY LEVERAGES
MEDICAL EXPERTISE AND TECHNOLOGICAL INNOVATION TO IMPROVE REGIONAL ACCESS
TO ADVANCED STROKE CARE AND ENDOVASCULAR TREATMENTS FOR ANEURYSM AND
VASCULAR MALFORMATIONS OF THE BRAIN.
W
ITH THE OPENING of its
new NeuroInterventional
S u r g e r y s e r v i c e i n
Fe br u a r y, f e a t u r i n g
Alison J. Nohara, MD, Director of
NeuroInterventional Surgery, and a
multimillion-dollar investment in a
Siemens Artis Q biplane angiography
suite, Health Quest has radically changed
the treatment options for stroke patients
in the Mid-Hudson Valley region.
There was a time not too long ago when
there was no effective treatment for an
acute stroke. If the patient survived the
stroke, the focus was on coping with
its devastating effects and minimizing
the risk of reoccurrence. Starting in
the mid-1990s, options for intervening
during a stroke became available, begin-
ning with the FDA approval of tissue
plasminogen activator (tPA) in 1996
Alison J. Nohara, MD
Health Quest Adds
Neurointerventional Surgery
to Maximize Vascular Care
By Carrie Frye
COV ER
FE AT UR E
Alison J. Nohara, MD, Director of
NeuroInterventional Surgery at Health
Quest's Vassar Brothers Medical
Center, evaluates a CT angiogram in
advance of consulting with a patient.
6
|
Mid Hudson MD NEWS ■ M D N E W S . CO M
